MEK and the inhibitors: from bench to bedside

Overview of attention for article published in Journal of Hematology & Oncology, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 1 X user
patent: 4 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 226 Dimensions

Readers on

mendeley: 176 Mendeley
citeulike: 1 CiteULike

Summary X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

PHARMACEUTICAL COMBINATIONS

Grant EP-3463345-B1

European Patent Office

Pyrrolopyridine-aniline compounds for treatment of dermal disorders

Grant AU-2018270295-B2

Australia

PYRROLOPYRIDINE-ANILINE COMPOUNDS FOR TREATMENT OF DERMAL DISORDERS

Application WO-2018213810-A1

World Intellectual Property Organisation (WIPO)

FUSED HETEROAROMATIC-ANILINE COMPOUNDS FOR TREATMENT OF DERMAL DISORDERS

Application WO-2018213807-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.